OSR HOLDINGS INC (OSRH)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.28+136.05%
Close 2026-08-31 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OSRH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -62.7% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
OSRH — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued
Dated 2026-08-19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 19, 2026, OSR Health, Inc. (the “Company”) received a Staff Determination Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq has determined to delist the Company’s common stock and warrants from the Nasdaq Capital Market. As previously disclosed, the Company was not in compliance with Nasdaq Listing Rule 5550(…
Why it matters: The appeal outcome will decide if OSRH stays on Nasdaq. If it is delisted, it could hurt investor confidence and liquidity.
Worry ifThe Nasdaq Hearings Panel grants OSRH's appeal and allows continued listing.
Less concerning ifThe Nasdaq Hearings Panel denies the appeal, leading to delisting of OSRH shares.
Why it matters: Progress on VXM01 can drive significant value for OSRH. Milestones can boost investor confidence.
Supportive ifOSRH says it has reached key clinical or regulatory goals for VXM01.
Worry ifDelays or setbacks in VXM01 development are reported.
Why it matters: If done well, this could increase value and loyalty for shareholders.
Supportive ifManagement says more people are joining the CVR program. Enrollment is going well.
Worry ifManagement reports few people are joining the CVR program. There are delays.
Why it matters: Nasdaq's decision will show if it accepts regulations. This could affect stock price stability.
Watch forNasdaq gives formal approval for the CVR program.
Also watch forNasdaq shows concerns or rejects the CVR program. This may cause stock price changes.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$405 on $10,000 · ±4.1% | How much price usually moves either way. |
| Bad day | $1,179 loss on $10,000 · 11.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,804 loss on $10,000 · 88.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The meeting's outcome can change governance and strategy. Delays may show internal problems.
Watch forThe Annual Meeting is now rescheduled. Important plans are now approved.
Also watch forThe meeting faces more delays. There may be issues among shareholders.
Why it matters: The August 14, 2026 record date is crucial for shareholder participation in the CVR program. This could impact shareholder sentiment and stock value.
Supportive ifMany shareholders join the CVR program by the record date.
Worry ifFew shareholders enroll. This shows they may not care or understand.
Why it matters: Successful M&A could help OSR Holdings grow and improve its financial situation.
Supportive ifOSR made a good purchase. This helps its market position.
Worry ifThere are no new M&A announcements. There are also no failed acquisition attempts.
Why it matters: Using the put option could give OSRH quick cash.
Supportive ifOSRH exercises the put option and receives $15 million in funding.
Worry ifOSRH does not exercise the put option within the specified timeframe.
Why it matters: Fixing legal issues can make OSR more stable. It can also boost investor trust.
Supportive ifThere is news about fixing legal problems or following rules.
Worry ifThere are new legal challenges. There are also delays in solving current issues.
Why it matters: BCME's commitment is important. It helps move VXM01 forward and aligns with shareholders.
Supportive ifBCME secures a major partnership or sublicensing deal for VXM01 within the next year.
Worry ifNo significant progress is made in securing partnerships for VXM01.
Why it matters: High trading volume may show how investors feel. It could also show recovery efforts.
Watch forTrading volume exceeds 100 million shares on the compliance deadline date.
Also watch forTrading volume is under 20 million shares. This suggests low investor interest.
Why it matters: Legal issues can affect how a company runs. Fixing them may help investors feel better.
Supportive ifA public announcement of a settlement or a good ruling in the case.
Worry ifMore legal issues or bad rulings that slow down the process.
Why it matters: Changes in trading volume can show how investors feel about OSRH's future.
Watch forTrading volume goes up a lot above the average of 18.5 million shares.
Also watch forTrading volume falls below the recent average. This shows less interest from investors.
Why it matters: Milestone payments could give OSRH important funds for growth and operations.
Supportive ifOSRH receives a milestone payment of at least $100 million tied to VXM01's clinical progress.
Worry ifNo milestone payments are received within the next six months.